Vin Milano Milano
Director/Board Member at ACLARIS THERAPEUTICS, INC.
Net worth: 458 545 $ as of 2024-05-30
Profile
Mr. Vincent J.
Milano, CPA, is an Independent Director at BioCryst Pharmaceuticals, Inc., an Independent Director at Aclaris Therapeutics, Inc. and a Chairman at Life Science Cares Philadelphia.
He is on the Board of Directors at BioCryst Pharmaceuticals, Inc., Aclaris Therapeutics, Inc. and Biotechnology Innovation Organization.
Mr. Milano was previously employed as a Chairman by Aceragen, Inc., a Chairman by Idera Pharmaceuticals, Inc., an Independent Director by Spark Therapeutics, Inc., an Independent Director by Vanda Pharmaceuticals, Inc., a Chairman by Life Sciences Pennsylvania, a Chairman, President & Chief Executive Officer by ViroPharma, Inc. /US/, and a Senior Manager by KPMG LLP.
He also served on the board at Venatorx Pharmaceuticals, Inc. and BravoSolution US, Inc. He received his undergraduate degree from Rider University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-30 | 67,867 ( 0.03% ) | 438 421 $ | 2024-05-30 | |
| 2024-05-31 | 12,523 ( 0.02% ) | 12 899 $ | 2024-05-30 | |
ACERAGEN, INC.
0.11% | 2023-08-09 | 8,987 ( 0.11% ) | 7 226 $ | 2023-07-30 |
Vin Milano Milano active positions
| Companies | Position | Start |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Director/Board Member | 2020-01-06 |
| BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 2021-07-25 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
| Life Science Cares Philadelphia | Chairman | - |
Former positions of Vin Milano Milano
| Companies | Position | End |
|---|---|---|
| ACERAGEN, INC. | Chairman | 2023-07-31 |
Venatorx Pharmaceuticals, Inc.
 Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Director/Board Member | 2022-12-19 |
| SPARK THERAPEUTICS, INC. | Director/Board Member | 2019-12-16 |
| VANDA PHARMACEUTICALS INC. | Director/Board Member | 2019-06-12 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Chief Executive Officer | 2013-12-31 |
Training of Vin Milano Milano
| Rider University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| VANDA PHARMACEUTICALS INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| ACERAGEN, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
BravoSolution US, Inc.
 BravoSolution US, Inc. Packaged SoftwareTechnology Services BravoSolution US, Inc. develops sourcing and supply management solutions. Its products cover the full supply management lifecycle including sourcing, spend analysis, vendor management, contract management, professional services and category expertise. The company was founded in 1995 and is headquartered in Malvern, PA. | Technology Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Commercial Services |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
| Life Science Cares Philadelphia |
- Stock Market
- Insiders
- Vin Milano Milano
